UnitedHealth Group (UNH) Stock Forecast & Price Target

$411.54 +2.31 (+0.56%)

As of 03:59 PM Eastern

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 24 Analyst Ratings

Sell
0

Hold
3

Buy
21

Based on 24 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 24 analysts, 3 have given a hold rating, 18 have given a buy rating, and 3 have given a strong buy rating for UNH.

Consensus Price Target

$596.86
45.03% Upside

According to the 24 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $596.86. The highest price target for UNH is $700.00, while the lowest price target for UNH is $490.00. The average price target represents a forecasted upside of 45.03% from the current price of $411.54.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

UNH Analyst Ratings Over Time

Type	Current Forecast 4/30/24 to 4/30/25	1 Month Ago 3/31/24 to 3/31/25	3 Months Ago 1/31/24 to 1/30/25	1 Year Ago 5/1/23 to 4/30/24
Strong Buy	3 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	18 Buy rating(s)	19 Buy rating(s)	19 Buy rating(s)	15 Buy rating(s)
Hold	3 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$596.86	$629.32	$629.32	$570.05
Forecasted Upside	45.03% Upside	19.99% Upside	15.41% Upside	17.85% Upside
Consensus Rating	Buy	Buy	Buy	Moderate Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.82	2.54
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	47.83% Upside	3,362.75% Upside	22.58% Upside
News Sentiment Rating	Positive News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/29/2025	Robert W. Baird 2 of 5 stars	Michael Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$640.00 ➝ $510.00	+21.42%
4/24/2025	JPMorgan Chase & Co. 2 of 5 stars	Lisa Gill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$652.00 ➝ $525.00	+23.02%
4/23/2025	Royal Bank of Canada 4 of 5 stars	Ben Hendrix Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$655.00 ➝ $525.00	+21.07%
4/22/2025	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Herholdt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/22/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ricky Goldwasser Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$664.00 ➝ $563.00	+32.86%
4/22/2025	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sidharth Sahoo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$490.00	+15.19%
4/21/2025	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$660.00 ➝ $580.00	+34.48%
4/21/2025	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tim Rezvan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$650.00 ➝ $575.00	+33.68%
4/21/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$642.00 ➝ $560.00	+30.19%
4/21/2025	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Ransom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$635.00 ➝ $540.00	+24.33%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
4/21/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$640.00 ➝ $600.00	+31.55%
4/21/2025	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
4/16/2025	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/9/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$600.00 ➝ $650.00	+17.37%
1/28/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$694.00 ➝ $660.00	+21.46%
1/17/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$700.00 ➝ $700.00	+36.71%
1/2/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$605.00 ➝ $600.00	+18.61%
12/5/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$605.00 ➝ $675.00	+10.54%
12/3/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$595.00 ➝ $625.00	+2.72%
10/18/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$601.00 ➝ $609.00	+7.84%
10/16/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$680.00 ➝ $650.00	+13.16%
10/16/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$675.00 ➝ $650.00	+17.23%
7/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$481.00 ➝ $647.00	+17.88%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/18/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$595.00 ➝ $603.00	+24.55%
6/14/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$625.00 ➝ $560.00	+13.98%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:19 PM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 23, 2025. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

The current stock price is around $433, which reflects a potential upside based on recent analyst price targets.
UnitedHealth Group has received multiple "outperform" ratings from analysts, indicating strong confidence in its future performance.
The company reported a robust revenue of over $109 billion in its latest earnings, showcasing its strong market position and operational efficiency.
With a market capitalization exceeding $396 billion, UnitedHealth Group is a significant player in the healthcare sector, providing stability and growth potential.
The firm has a solid dividend yield of approximately 1.97%, offering investors a return on investment through regular income.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

The stock has experienced a decline from its 52-week high of around $630, which may indicate volatility and potential risks in the market.
Recent earnings results showed a slight miss on EPS estimates, which could raise concerns about the company's short-term performance.
Analysts have recently lowered price targets, suggesting a more cautious outlook on the stock's future growth.
The company has a relatively high P/E ratio, which may indicate that the stock is overvalued compared to its earnings potential.
With a debt-to-equity ratio of 0.74, there are concerns about the company's leverage and financial stability in a changing economic environment.

UNH Forecast - Frequently Asked Questions

: According to the research reports of 24 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $596.86, with a high forecast of $700.00 and a low forecast of $490.00.
: 24 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There are currently 3 hold ratings, 18 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" UNH shares.
: According to analysts, UnitedHealth Group's stock has a predicted upside of 45.03% based on their 12-month stock forecasts.
: Over the previous 90 days, UnitedHealth Group's stock had 2 downgrades and 1 upgrade by analysts.
: UnitedHealth Group has been rated by research analysts at Argus, Barclays, Erste Group Bank, Hsbc Global Res, HSBC, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Oppenheimer, Raymond James, Robert W. Baird, Royal Bank of Canada, and Truist Financial in the past 90 days.
: Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating for UnitedHealth Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:UNH) was last updated on 4/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target